FDA approves Pfizer COVID-19 booster for children

May 17th, 20220 WASHINGTON D.C. — The U.S. Food and Drug Administration (FDA) has announced expanded approval for Pfizer’s COVID-19 booster shot. Now, children ages 5-11 are now eligible for the COVID-19 booster shot made by Pfizer-BioNTech and which is recommended at least five months after the initial two-dose series of the vaccine. The...

Pfizer asks FDA for emergency approval for COVID-19 vaccine for children under 5

February 2nd, 20220 WASHINGTON D.C. — Pfizer-BioNTech has asked the FDA for emergency authorization for a two-dose COVID-19 vaccine for children 6-months- to 5-years-old. The company is still awaiting data on a three-dose course. Early data from Pfizer has shown that the vaccine is safe and produces an immune response. For the youngest age group,...